Current topics in occupational asthma

Expert Review of Respiratory Medicine

Volumn 6, Issue 6, 2012, Pages 615-627

  Burge, Sherwood ^a   Hoyle, Jennifer ^b  

^a BIRMINGHAM HEARTLANDS HOSPITAL   (United Kingdom)

^b NORTH MANCHESTER GENERAL HOSPITAL   (United Kingdom)

Author keywords

aldehyde receptors; costs; irritant asthma; Oasys; occupational asthma; phenotype; prognosis

Indexed keywords

ACREOLIN; ALLYL ISOTHIOCYANATE; CHLORINE; CINNAMALDEHYDE; GLUTATHIONE TRANSFERASE; IMMUNOGLOBULIN E; IRRITANT AGENT; NITRIC OXIDE; TRANSIENT RECEPTOR POTENTIAL CHANNEL A1; UNCLASSIFIED DRUG;

ALLERGENICITY; COLD AIR; COST BENEFIT ANALYSIS; DISEASE SURVEILLANCE; FORCED EXPIRATORY VOLUME; GENOTYPE; GOLD STANDARD; HEALTH CARE PERSONNEL; HUMAN; LUNG FUNCTION; NONHUMAN; OCCUPATIONAL ASTHMA; OCCUPATIONAL EXPOSURE; PATHOGENESIS; PEAK EXPIRATORY FLOW; PHENOTYPE; PRICK TEST; PROGNOSIS; REVIEW; SCREENING TEST; WORKPLACE;

EID: 84870990337     PISSN: 17476348     EISSN: 17476356     Source Type: Journal    
DOI: 10.1586/ers.12.65     Document Type: Review

References (86)

1. Nicholson PJ, Cullinan P, Taylor AJ, Burge PS, Boyle C. Evidence based guidelines for the prevention, identification, and management of occupational asthma. Occup. Environ. Med. 62(5), 290-299 (2005). (Pubitemid 40592488)
2. Baur X, Sigsgaard T, Aasen TB et al.; ERS Task Force on the Management of Work-related Asthma. Guidelines for the management of work-related asthma. Eur. Respir. J. 39(3), 529-545 (2012).
3. Beach J, Russell K, Blitz S et al. A systematic review of the diagnosis of occupational asthma. Chest 131(2), 569-578 (2007). (Pubitemid 46280421)
4. Moore VC, Jaakkola MS, Burge PS. A systematic review of serial peak expiratory flow measurements in the diagnosis of occupational asthma. Annals of Respiratory Medicine. 1, 31-44 (2010).
5. de Groene GJ, Pal TM, Beach J et al. Workplace interventions for treatment of occupational asthma. Cochrane Database Syst. Rev. 5, CD006308 (2011).
6. Rachiotis G, Savani R, Brant A, MacNeill SJ, Newman Taylor A, Cullinan P. Outcome of occupational asthma after cessation of exposure: a systematic review. Thorax 62(2), 147-152 (2007).
7. Tarlo SM, Balmes J, Balkissoon R et al. Diagnosis and management of work-related asthma: American College Of Chest Physicians Consensus Statement. Chest 134(Suppl. 3), 1S-41S (2008).
8. Henneberger PK, Redlich CA, Callahan DB et al.; ATS Ad Hoc Committee on Work-Exacerbated Asthma. An official American Thoracic Society statement: work-exacerbated asthma. Am. J. Respir. Crit. Care Med. 184(3), 368-378 (2011).
9. Nicholson PJ, Cullinan P, Burge PS, Boyle C. Occupational asthma: prevention, identification and management: systematic review and recommendations. British Occupational Health Research Foundation (2010).
10. Maestrelli P, Schlünssen V, Mason P, Sigsgaard T; ERS Task Force on the Management of Work-related Asthma. Contribution of host factors and workplace exposure to the outcome of occupational asthma. Eur. Respir. Rev. 21(124), 88-96 (2012).
11. Fishwick D, Bradshaw L, Davies J et al. Are we failing workers with symptoms suggestive of occupational asthma? Prim. Care Respir. J. 16(5), 304-310 (2007). (Pubitemid 47607073)
12. Fishwick D, Barber CM, Bradshaw LM et al. Standards of care for occupational asthma: an update. Thorax 67(3), 278-280 (2012).
13. Bernton HS. On occupational sensitisation to the castor bean. Am. J. Med. Sci. 165, 196-202 (1923).
14. Clarke JA, Meyer GP. A case of hypersensitivity to silk. JAMA 80, 11-12 (1923).
15. Hunter D, Milton R, Perry KMA. Asthma caused by the complex salts of platinum. Brit. J. Industr. Med. 2, 92-98 (1945).
16. Pepys J, Pickering CA, Hughes EG. Asthma due to inhaled chemical agents -complex salts of platinum. Clin. Allergy 2(4), 391-396 (1972).
17. McDonald JC, Keynes HL, Meredith SK. Reported incidence of occupational asthma in the United Kingdom, 1989-97. Occup. Environ. Med. 57(12), 823-829 (2000).
18. Bakerly ND, Moore VC, Vellore AD, Jaakkola MS, Robertson AS, Burge PS. Fifteen-year trends in occupational asthma: data from the Shield surveillance scheme. Occup. Med. (Lond.) 58(3), 169-174 (2008).
19. Tee RD, Cullinan P, Welch J, Burge PS, Newman-Taylor AJ. Specific IgE to isocyanates: a useful diagnostic role in occupational asthma. J. Allergy Clin. Immunol. 101(5), 709-715 (1998). (Pubitemid 28228317)
20. Chan-Yeung M, Barton GM, MacLean L, Grzybowski S. Occupational asthma and rhinitis due to Western red cedar (Thuja plicata). Am. Rev. Respir. Dis. 108(5), 1094-1102 (1973).
21. Burge PS, Harries MG, O'Brien I, Pepys J. Bronchial provocation studies in workers exposed to the fumes of electronic soldering fluxes. Clin. Allergy 10(2), 137-149 (1980).
22. Ramazzini B. Diseases of dressers of flax and hemp and carders of silk rolls. In: De Morbus Artificum Diatriba. Tr Wilmer Wright, Chicago, IL, USA (1713)
23. Baur X, Posch A. Characterized allergens causing bakers' asthma. Allergy 53(6), 562-566 (1998). (Pubitemid 28307923)
24. Karjalainen A, Martikainen R, Oksa P, Saarinen K, Uitti J. Incidence of asthma among Finnish construction workers. J. Occup. Environ. Med. 44(8), 752-757 (2002).
25. Burge PS, Moore VC, Robertson AS. Sensitization and irritant-induced occupational asthma with latency are clinically indistinguishable. Occup. Med. (Lond.) 62(2), 129-133 (2012).
26. Sears MR, Burrows B, Flannery EM, Herbison GP, Hewitt CJ, Holdaway MD. Relation between airway responsiveness and serum IgE in children with asthma and in apparently normal children. N. Engl. J. Med. 325(15), 1067-1071 (1991).
27. Mapp CE, Fryer AA, De Marzo N et al. Glutathione S-transferase GSTP1 is a susceptibility gene for occupational asthma induced by isocyanates. J. Allergy Clin. Immunol. 109(5), 867-872 (2002). (Pubitemid 34499523)
28. Anderson GP. Endotyping asthma: new insights into key pathogenic mechanisms in a complex, heterogeneous disease. Lancet 372(9643), 1107-1119 (2008).
29. Simpson JL, Scott R, Boyle MJ, Gibson PG. Inflammatory subtypes in asthma: assessment and identification using induced sputum. Respirology 11(1), 54-61 (2006).
30. Moore VC, Anees W, Jaakkola MS, Burge CB, Robertson AS, Burge PS. Two variants of occupational asthma separable by exhaled breath nitric oxide level. Respir. Med. 104(6), 873-879 (2010).
31. Anees W, Huggins V, Pavord ID, Robertson AS, Burge PS. Occupational asthma due to low molecular weight agents: eosinophilic and non-eosinophilic variants. Thorax 57(3), 231-236 (2002). (Pubitemid 34214409)
32. Le Moual N, Siroux V, Pin I, Kauffmann F, Kennedy SM; Epidemiological Study on the Genetics and Environment of Asthma. Asthma severity and exposure to occupational asthmogens. Am. J. Respir. Crit. Care Med. 172(4), 440-445 (2005). (Pubitemid 41117389)
33. Wenzel SE. Asthma: defining of the persistent adult phenotypes. Lancet 368(9537), 804-813 (2006). (Pubitemid 44279058)
34. Taylor AJ. HLA phenotype and exposure in development of occupational asthma. Ann. Allergy Asthma Immunol. 90(5 Suppl. 2), 24-27 (2003). (Pubitemid 36828133)
35. Brooks SM, Weiss MA, Bernstein IL. Reactive airways dysfunction syndrome (RADS). Persistent asthma syndrome after high level irritant exposures. Chest 88(3), 376-384 (1985). (Pubitemid 15248096)
36. Brooks SM, Hammad Y, Richards I, Giovinco-Barbas J, Jenkins K. The spectrum of irritant-induced asthma: sudden and not-so-sudden onset and the role of allergy. Chest 113(1), 42-49 (1998). (Pubitemid 28044922)
37. Tarlo SM, Broder I. Irritant-induced occupational asthma. Chest 96(2), 297-300 (1989). (Pubitemid 19199539)
38. Vandenplas O, Dargent F, Auverdin JJ et al. Occupational asthma due to gas metal arc welding on mild steel. Thorax 50(5), 587-588: discussion 589 (1995).
39. Adewole F, Moore VC, Robertson AS, Burge PS. Diesel exhaust causing low-dose irritant asthma with latency? Occup. Med. (Lond.) 59(6), 424-427 (2009).
40. Thickett KM, McCoach JS, Gerber JM, Sadhra S, Burge PS. Occupational asthma caused by chloramines in indoor swimming-pool air. Eur. Respir. J. 19(5), 827-832 (2002). (Pubitemid 34567894)
41. Burge PS, Harries MG, Lam WK, O'Brien IM, Patchett PA. Occupational asthma due to formaldehyde. Thorax 40(4), 255-260 (1985). (Pubitemid 15105940)
42. Di Stefano F, Siriruttanapruk S, McCoach J, Burge PS. Glutaraldehyde: an occupational hazard in the hospital setting. Allergy 54(10), 1105-1109 (1999). (Pubitemid 29482011)
43. Vyas A, Pickering CA, Oldham LA et al. Survey of symptoms, respiratory function, and immunology and their relation to glutaraldehyde and other occupational exposures among endoscopy nursing staff. Occup. Environ. Med. 57(11), 752-759 (2000).
44. Verstraelen S, Bloemen K, Nelissen I, Witters H, Schoeters G, Van Den Heuvel R. Cell types involved in allergic asthma and their use in in vitro models to assess respiratory sensitization. Toxicol. In Vitro 22(6), 1419-1431 (2008).
45. Palczynski C, Walusiak J, Ruta U, Górski P. Occupational asthma and rhinitis due to glutaraldehyde: changes in nasal lavage fluid after specific inhalatory challenge test. Allergy 56(12), 1186-1191 (2001). (Pubitemid 33086980)
46. Raemdonck K, de Alba J, Birrell MA et al. A role for sensory nerves in the late asthmatic response. Thorax 67(1), 19-25 (2012).
47. Birrell MA, Belvisi MG, Grace M et al. TRPA1 agonists evoke coughing in guinea pig and human volunteers. Am. J. Respir. Crit. Care Med. 180(11), 1042-1047 (2009).
48. Peters SP, Kunselman SJ, Icitovic N et al.; National Heart, Lung, and Blood Institute Asthma Clinical Research Network. Tiotropium bromide step-up therapy for adults with uncontrolled asthma. N. Engl. J. Med. 363(18), 1715-1726 (2010).
49. Bautista DM, Jordt SE, Nikai T et al. TRPA1 mediates the inflammatory actions of environmental irritants and proalgesic agents. Cell 124(6), 1269-1282 (2006).
50. Anees W, Moore VC, Burge PS. FEV1 decline in occupational asthma. Thorax 61(9), 751-755 (2006).
51. Surange N, Hoyle J. Occupational asthma; is this the cause of excess respiratory symptoms and COPD described in bitumen exposed workers? Thorax 66, A5-A6 (2011).
52. Randem BG, Ulvestad B, Burstyn I, Kongerud J. Respiratory symptoms and airflow limitation in asphalt workers. Occup. Environ. Med. 61(4), 367-369 (2004). (Pubitemid 39214554)
53. Raulf-Heimsoth M, Pesch B, Schott K et al. Irritative effects of fumes and aerosols of bitumen on the airways: results of a cross-shift study. Arch. Toxicol. 81(1), 35-44 (2007). (Pubitemid 46115456)
54. Dearman RJ, Basketter DA, Kimber I. Local lymph node assay: use in hazard and risk assessment. J. Appl. Toxicol. 19(5), 299-306 (1999). (Pubitemid 29452573)
55. Dearman RJ, Kimber I. Cytokine fingerprinting and hazard assessment of chemical respiratory allergy. J. Appl. Toxicol. 21(2), 153-163 (2001). (Pubitemid 32288363)
56. Seed M, Agius R. Further validation of computer-based prediction of chemical asthma hazard. Occup. Med. (Lond.) 60(2), 115-120 (2010).
57. Jarvis J, Seed MJ, Elton R, Sawyer L, Agius R. Relationship between chemical structure and the occupational asthma hazard of low molecular weight organic compounds. Occup. Environ. Med. 62(4), 243-250 (2005).
58. Drought VJ, Francis HC, McLR Niven P, Burge PS. Occupational asthma induced by thiamine in a vitamin supplement for breakfast cereals. Allergy 60(9), 1213-1214 (2005). (Pubitemid 41153154)
59. Vellore AD, Madathil S, Heinink RA et al. Vitamins as asthmagens in the workplace. Eur. Respir. J. 32(3), 819-820; author reply 820 (2008).
60. Gautrin D, Infante-Rivard C, Dao TV, Magnan-Larose M, Desjardins D, Malo JL. Specific IgE-dependent sensitization, atopy, and bronchial hyperresponsiveness in apprentices starting exposure to proteinderived agents. Am. J. Respir. Crit. Care Med. 155(6), 1841-1847 (1997). (Pubitemid 27256107)
61. Gautrin D, Infante-Rivard C, Ghezzo H, Malo JL. Incidence and host determinants of probable occupational asthma in apprentices exposed to laboratory animals. Am. J. Respir. Crit. Care Med. 163(4), 899-904 (2001). (Pubitemid 32275861)
62. Baur X, Degens PO, Sander I. Baker's asthma: still among the most frequent occupational respiratory disorders. J. Allergy Clin. Immunol. 102(6 Pt 1), 984-997 (1998). (Pubitemid 29018316)
63. Vandenplas O, Malo JL, Cartier A, Perreault G, Cloutier Y. Closed-circuit methodology for inhalation challenge tests with isocyanates. Am. Rev. Respir. Dis. 145(3), 582-587 (1992).
64. Cloutier Y, Lagier F, Lemieux R et al. New methodology for specific inhalation challenges with occupational agents in powder form. Eur. Respir. J. 2(8), 769-777 (1989).
65. Rioux JP, Malo JL, L'Archevêque J, Rabhi K, Labrecque M. Workplace-specific challenges as a contribution to the diagnosis of occupational asthma. Eur. Respir. J. 32(4), 997-1003 (2008).
66. Stenton SC, Avery AJ, Walters EH, Hendrick DJ. Statistical approaches to the identification of late asthmatic reactions. Eur. Respir. J. 7(4), 806-812 (1994). (Pubitemid 24122979)
67. Chiry S, Cartier A, Malo JL, Tarlo SM, Lemière C. Comparison of peak expiratory flow variability between workers with work-exacerbated asthma and occupational asthma. Chest 132(2), 483-488 (2007). (Pubitemid 47282380)
68. Anees W, Gannon PF, Huggins V, Pantin CF, Burge PS. Effect of peak expiratory flow data quantity on diagnostic sensitivity and specificity in occupational asthma. Eur. Respir. J. 23(5), 730-734 (2004). (Pubitemid 38618144)
69. Moore VC, Jaakkola MS, Burge CB et al. PEF analysis requiring shorter records for occupational asthma diagnosis. Occup. Med. (Lond.) 59(6), 413-417 (2009).
70. Malo JL, Cartier A, Ghezzo H, Chan-Yeung M. Compliance with peak expiratory flow readings affects the within-and between-reader reproducibility of interpretation of graphs in subjects investigated for occupational asthma. J. Allergy Clin. Immunol. 98, 1132-1134 (1996). (Pubitemid 27014813)
71. Malo JL, Trudeau C, Ghezzo H, L'Archevêque J, Cartier A. Do subjects investigated for occupational asthma through serial peak expiratory flow measurements falsify their results? J. Allergy Clin. Immunol. 96(5 Pt 1), 601-607 (1995).
72. Kennedy WA, Girard F, Chaboillez S et al. Cost-effectiveness of various diagnostic approaches for occupational asthma. Can. Respir. J. 14(5), 276-280 (2007). (Pubitemid 47527459)
73. Moore VC, Burge PS. Occupational asthma to solder wire containing an adipic acid flux. Eur. Respir. J. 36(4), 962-963 (2010).
74. Huggins V, Anees W, Pantin C, Burge S. Improving the quality of peak flow measurements for the diagnosis of occupational asthma. Occup. Med. (Lond.) 55(5), 385-388 (2005). (Pubitemid 41158562)
75. Robertson W, Robertson AS, Burge CB et al. Clinical investigation of an outbreak of alveolitis and asthma in a car engine manufacturing plant. Thorax 62(11), 981-990 (2007). (Pubitemid 350084498)
76. Gannon PF, Newton DT, Belcher J, Pantin CF, Burge PS. Development of OASYS-2: a system for the analysis of serial measurement of peak expiratory flow in workers with suspected occupational asthma. Thorax 51(5), 484-489 (1996). (Pubitemid 26161865)
77. Moore VC, Jaakkola MS, Burge CB et al. A new diagnostic score for occupational asthma: the area between the curves (ABC score) of peak expiratory flow on days at and away from work. Chest 135(2), 307-314 (2009).
78. Moore VC, Jaakkola MS, Burge CB, Pantin CF, Robertson AS, Burge PS. Do long periods off work in peak expiratory flow monitoring improve the sensitivity of occupational asthma diagnosis? Occup. Environ. Med. 67(8), 562-567 (2010).
79. Burge CB, Moore VC, Pantin CF, Robertson AS, Burge PS. Diagnosis of occupational asthma from time point differences in serial PEF measurements. Thorax 64(12), 1032-1036 (2009).
80. Baur X, Aasen TB, Burge PS et al.; ERS Task Force on the Management of Work-related Asthma. The management of work-related asthma guidelines: a broader perspective. Eur. Respir. Rev. 21(124), 125-139 (2012).
81. Karlsson AS, Andersson B, Renström A, Svedmyr J, Larsson K, Borres MP. Airborne cat allergen reduction in classrooms that use special school clothing or ban pet ownership. J. Allergy Clin. Immunol. 113(6), 1172-1177 (2004). (Pubitemid 38858002)
82. Hnizdo E, Yu L, Freyder L, Attfield M, Lefante J, Glindmeyer HW. The precision of longitudinal lung function measurements: monitoring and interpretation. Occup. Environ. Med. 62(10), 695-701 (2005). (Pubitemid 41360895)
83. Burge PS. Who bears the costs of occupational asthma? Thorax 66(2), 92-93 (2011).
84. Ayres JG, Boyd R, Cowie H, Hurley JF. Costs of occupational asthma in the UK. Thorax 66(2), 128-133 (2011).
85. Miedinger D, Malo JL, Ghezzo H, L'Archevêque J, Zunzunegui MV. Factors influencing duration of exposure with symptoms and costs of occupational asthma. Eur. Respir. J. 36(4), 728-734 (2010).
86. Asthma in the workplace. Fourth edition. Bernstein IL: Chan-Yeung M, Malo JL, Bernstein DI (Eds). Informa Healthcare, Zug, Switzerland (2013) (In Press).